Executive summaries on hypertension I. Initial evaluation and nondrug therapies

Research output: Contribution to journalArticle

Abstract

As defined in the sixth report of the U.S. Joint National Committee (JNC-VI), additional risk factors beyond accurately measured blood pressure should be considered in making the decision to institute drug therapy for hypertension. Lifestyle modifications should be strongly advocated for all patients, and may safely be used alone in those who are at relatively low overall risk, even if the blood pressure is as high as 160/100 mmHg.

Original languageEnglish (US)
Pages (from-to)707-713
Number of pages7
JournalDrugs of Today
Volume33
Issue number10
StatePublished - 1997

Fingerprint

Blood Pressure
Hypertension
Life Style
Decision Making
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Executive summaries on hypertension I. Initial evaluation and nondrug therapies. / Kaplan, Norman M.

In: Drugs of Today, Vol. 33, No. 10, 1997, p. 707-713.

Research output: Contribution to journalArticle

@article{44656906fe664d6e8f6f57ac1ca02ada,
title = "Executive summaries on hypertension I. Initial evaluation and nondrug therapies",
abstract = "As defined in the sixth report of the U.S. Joint National Committee (JNC-VI), additional risk factors beyond accurately measured blood pressure should be considered in making the decision to institute drug therapy for hypertension. Lifestyle modifications should be strongly advocated for all patients, and may safely be used alone in those who are at relatively low overall risk, even if the blood pressure is as high as 160/100 mmHg.",
author = "Kaplan, {Norman M}",
year = "1997",
language = "English (US)",
volume = "33",
pages = "707--713",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "10",

}

TY - JOUR

T1 - Executive summaries on hypertension I. Initial evaluation and nondrug therapies

AU - Kaplan, Norman M

PY - 1997

Y1 - 1997

N2 - As defined in the sixth report of the U.S. Joint National Committee (JNC-VI), additional risk factors beyond accurately measured blood pressure should be considered in making the decision to institute drug therapy for hypertension. Lifestyle modifications should be strongly advocated for all patients, and may safely be used alone in those who are at relatively low overall risk, even if the blood pressure is as high as 160/100 mmHg.

AB - As defined in the sixth report of the U.S. Joint National Committee (JNC-VI), additional risk factors beyond accurately measured blood pressure should be considered in making the decision to institute drug therapy for hypertension. Lifestyle modifications should be strongly advocated for all patients, and may safely be used alone in those who are at relatively low overall risk, even if the blood pressure is as high as 160/100 mmHg.

UR - http://www.scopus.com/inward/record.url?scp=0031461709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031461709&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 707

EP - 713

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 10

ER -